These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3245850)

  • 21. Feasibility study for transdermal delivery of meperidine.
    Ritschel WA; Barkhaus JK
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):461-5. PubMed ID: 3419250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
    Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
    Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of osthole-loaded nano-vesicles for skin delivery: Characterization, in vitro skin permeation and preliminary in vivo pharmacokinetic studies.
    Meng S; Zhang C; Shi W; Zhang XW; Liu DH; Wang P; Li JX; Jin Y
    Eur J Pharm Sci; 2016 Sep; 92():49-54. PubMed ID: 27349691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
    Paudel KS; Hammell DC; Agu RU; Valiveti S; Stinchcomb AL
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1088-97. PubMed ID: 20545522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pH and complexation on transdermal permeation of gliquidone.
    Sridevi S; Diwan PV
    Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transdermal delivery of insulin].
    Sevast'ianov VI; Salomatina LA; Kuznetsova EG; Iakovleva NV; Shumakov VI
    Med Tekh; 2003; (2):21-4. PubMed ID: 12924217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD; Nauert C; Ehrly AM
    Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
    Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
    Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coumarin derivatives, but not coumarin itself, cause skin irritation via topical delivery.
    Pan TL; Wang PW; Aljuffali IA; Leu YL; Hung YY; Fang JY
    Toxicol Lett; 2014 Apr; 226(2):173-81. PubMed ID: 24561300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of dimethylacetamide, N-N-diethyl-m-toluamide and 1-dodecylazacycloheptan-2-one on ex vivo permeation of phosphonoformic acid through rat skin.
    Hussain AS; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):691-4. PubMed ID: 2975739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and evaluation of matrix diffusion controlled transdermal patches of coumarin.
    Prabu SL; Thiyagarajan S; Suriyaprakash TN
    Curr Drug Deliv; 2013 Apr; 10(2):167-73. PubMed ID: 22998642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal drug delivery of meperidine.
    Ritschel WA; Sathyan G; Denson DD
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):165-72. PubMed ID: 2725115
    [No Abstract]   [Full Text] [Related]  

  • 37. Membrane-controlled transdermal therapeutic system containing clonazepam and anticonvulsant activity after its application.
    Ogiso T; Ito Y; Iwaki M; Yamamoto Y
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):446-9. PubMed ID: 2743491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous absorption and metabolism of Coumarin in human and rat skin.
    Yourick JJ; Bronaugh RL
    J Appl Toxicol; 1997; 17(3):153-8. PubMed ID: 9250536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal delivery of metoprolol. II: In-vitro skin permeation and bioavailability in hairless rats.
    Ghosh TK; Adir J; Xiang SL; Onyilofur S
    J Pharm Sci; 1995 Feb; 84(2):158-60. PubMed ID: 7738793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot study on bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained-release dosage form.
    Ritschel WA; Hoffmann KA
    J Clin Pharmacol; 1981 Jul; 21(7):294-300. PubMed ID: 7263928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.